V. Chromikova, A. Mader, W. Steinfellner, and R. Kunert, Evaluating the bottlenecks of recombinant IgM production in mammalian cells, Cytotechnology, vol.67, issue.2, pp.343-356, 2014.

Y. Azuma, Y. Ishikawa, S. Kawai, T. Tsunenari, H. Tsunoda et al., Recombinant human hexamerdominant IgM monoclonal antibody to ganglioside GM3 for treatment of melanoma, Clin Cancer Res, vol.13, pp.2745-2750, 2007.

A. Tchoudakova, F. Hensel, A. Murillo, B. Eng, M. Foley et al., High level expression of functional human IgMs in human PER.C6® cells, MAbs, vol.1, pp.163-171, 2009.

M. Tarköy, M. Wyss, and M. P. Rudolf, A comparative characterization of dipentameric (IgM)2 and pentameric IgM species present in preparations of a monoclonal IgM for therapeutic use, J Pharm Biomed Anal, vol.51, pp.1084-1090, 2010.

J. W. Brewer and R. B. Corley, Quality control in protein biogenesis: thiol-mediated retention monitors the redox state of proteins in the endoplasmic reticulum, J Cell Sci, vol.109, pp.2383-92, 1996.

K. Vorauer-uhl, J. Wallner, G. Lhota, H. Katinger, and R. Kunert, IgM characterization directly performed in crude culture supernatants by a new simple electrophoretic method, Journal of Immunological Methods, vol.359, issue.1-2, pp.21-27, 2010.

S. Muraoka and M. J. Shulman, Effects of mutations in the oligosaccharide acceptor site at Asn402, J Immunol, vol.142, pp.695-701, 1989.

C. H. Chung, B. Mirakhur, E. Chan, Q. Le, J. Berlin et al., Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-?-1,3-Galactose, New England Journal of Medicine, vol.358, issue.11, pp.1109-1117, 2008.

R. Sitia, A. Rubartelli, U. Hämmerling, and R. , The role of glycosylation in secretion and membrane expression of immunoglobulins M and A, Mol Immunol, vol.21, issue.84, pp.90023-90026, 1984.

F. Higel, A. Seidl, F. Sörgel, and W. Friess, N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins, Eur J Pharm Biopharm, vol.100, pp.94-100, 2016.

Y. Durocher, S. Perret, and A. Kamen, High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells, Nucleic Acids Research, vol.30, issue.2, pp.9e-9, 2002.

V. Jä-ger, K. Bü-ssow, A. Wagner, S. Weber, M. Hust et al., High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells, BMC Biotechnol, vol.13, pp.1-20, 2013.

L. Schwaigerlehner, P. Mayrhofer, M. Diem, W. Steinfellner, E. Fenech et al., Germinality does not necessarily define mAb expression and thermal stability, Applied Microbiology and Biotechnology, vol.103, issue.18, pp.7505-7518, 2019.

M. Derouazi, D. Martinet, B. Schmutz, N. Flaction, R. Wicht et al., Genetic characterization of CHO production host DG44 and derivative recombinant cell lines, Biochem Biophys Res Commun, vol.340, pp.1069-1077, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00399577

C. M. Gorman, D. Gies, G. Mccray, and M. Huang, The human cytomegalovirus major immediate early promoter can be trans-activated by adenovirus early proteins, Virology, vol.171, pp.377-385, 1989.

G. Backliwal, M. Hildinger, I. Kuettel, F. Delegrange, D. L. Hacker et al., Valproic acid: A viable alternative to sodium butyrate for enhancing protein expression in mammalian cell cultures, Biotechnol Bioeng, vol.101, pp.182-189, 2008.

P. L. Pham, S. Perret, B. Cass, E. Carpentier, .. St et al., Transient gene expression in HEK293 cells: Peptone addition posttransfection improves recombinant protein synthesis, Biotechnol Bioeng, vol.90, pp.332-344, 2005.

J. Hennicke, A. M. Lastin, D. Reinhart, C. Grü-nwald-gruber, F. Altmann et al., Glycan profile of CHO derived IgM purified by highly efficient single step affinity chromatography, Anal Biochem, vol.539, pp.162-166, 2017.

J. Heukeshoven and R. Dernick, Simplified Method for Silver Staining of Proteins in Polyacrylamide Gels and the Mechanism of Silver Staining, Electrophoresis, vol.6, pp.103-112, 1985.

I. Bally, A. Inforzato, F. Dalonneau, M. Stravalaci, B. Bottazzi et al., Interaction of C1q with pentraxin 3 and IgM revisited: Mutational studies with recombinant C1q variants, Front Immunol, vol.10, pp.1-12, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02068492

G. J. Arlaud, R. B. Sim, A. Duplaa, and M. G. Colomb, Differential elution of Clq, Cl?r and Cl?s from human CT bound to immune aggregates. use in the rapid purification of Cl? sub-components, Molecular Immunology, vol.16, issue.7, pp.445-450, 1979.

J. Hennicke, D. Reinhart, F. Altmann, and R. Kunert, Impact of temperature and pH on recombinant human IgM quality attributes and productivity, N Biotechnol, vol.50, pp.20-26, 2019.

J. N. Arnold, M. R. Wormald, D. M. Suter, C. M. Radcliffe, D. J. Harvey et al., Human Serum IgM Glycosylation, Journal of Biological Chemistry, vol.280, issue.32, pp.29080-29087, 2005.

A. Feinstein and E. A. Munn, Conformation of the Free and Antigen-bound IgM Antibody Molecules, Nature, vol.224, issue.5226, pp.1307-1309, 1969.

D. M. Czajkowsky and Z. Shao, The human IgM pentamer is a mushroom-shaped molecule with a flexural bias, Proceedings of the National Academy of Sciences, vol.106, issue.35, pp.14960-14965, 2009.

R. R. Akhouri, S. Goel, H. Furusho, U. Skoglund, and M. Wahlgren, Architecture of Human IgM in Complex with P. falciparum Erythrocyte Membrane Protein 1, Cell Rep, vol.14, pp.723-736, 2016.

B. Taylor, J. F. Wright, S. Arya, D. E. Isenman, M. J. Shulman et al., C1q binding properties of monomer and polymer forms of mouse IgM mu-chain variants. Pro544Gly and Pro434Ala, J Immunol, vol.153, pp.5303-5313, 1994.

J. F. Wright, M. J. Shulman, D. E. Isenman, and R. H. Painter, C1 binding by mouse IgM. The effect of abnormal glycosylation at position 402 resulting from a serine to asparagine exchange at residue 406 of the ?chain, J Biol Chem, vol.265, pp.10506-10513, 1990.

P. Hossler, S. F. Khattak, and Z. J. Li, Optimal and consistent protein glycosylation in mammalian cell culture, Glycobiology, vol.19, issue.9, pp.936-949, 2009.

A. Croset, L. Delafosse, J. Gaudry, C. Arod, L. Glez et al., Differences in the glycosylation of recombinant proteins expressed in HEK and CHO cells, Journal of Biotechnology, vol.161, issue.3, pp.336-348, 2012.

D. K. Robinson, C. Cp, C. Y. Ip, T. Pk, J. Tung et al., Characterization of a Recombinant Antibody Produced in the Course of a High-Yield Fed-Batch Process, Biotechnol Bioeng, vol.44, pp.727-735, 1994.

C. Q. Reid, A. Tait, H. Baldascini, A. Mohindra, A. Racher et al., Rapid whole monoclonal antibody analysis by mass spectrometry: An ultra scale-down study of the effect of harvesting by centrifugation on the post-translational modification profile, Biotechnol Bioeng, vol.107, pp.85-95, 2010.

A. C. Vestrheim, A. Moen, W. Egge-jacobsen, D. B. Bratlie, and T. E. Michaelsen, Different Glycosylation Pattern of Human IgG1 and IgG3 Antibodies Isolated From Transiently as Well as Permanently Transfected Cell Lines, Scandinavian Journal of Immunology, vol.78, issue.1, pp.108-110, 2013.

G. Morell, G. Gregoriadis, and I. H. Scheinberg, The Role of Sialic Acid in Determining Glycoproteins in the Circulation * the Survival of, 1971.

F. Wright, J. Shulmant, M. J. Isenman, D. E. Painter, and R. H. , C1 Binding by Mouse IgM, J Biol Chem, vol.265, pp.10506-10513, 1990.

M. De-los, M. Bassani-molinas, C. Beer, F. Hesse, M. Wirth et al., Optimizing the transient transfection process of HEK-293 suspension cells for protein production by nucleotide ratio monitoring, Cytotechnology, vol.66, p.23775287, 2014.

J. B. Goh and S. K. Ng, Impact of host cell line choice on glycan profile, Critical Reviews in Biotechnology, vol.38, issue.6, pp.851-867, 2017.

Y. Zeng, S. Fest, R. Kunert, H. Katinger, V. Pistoia et al., Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice, Mol Immunol, vol.42, pp.1311-1319, 2005.